Concurrent Session 5A: Abstract Session - National innovations in viral hepatitis
Tracks
.
Saturday, August 3, 2024 |
11:45 AM - 12:45 PM |
Auditorium 2 |
Speaker
VH2024 Conference
Welcome & Introduction
11:45 AM - 11:50 AMBiography
Ms Nicole Matthews
Research Coordinator
Burnet Institute
Effective use of Notifications Data to Advance Hepatitis C Elimination by 2030
11:50 AM - 12:05 PMBiography
As the Research Coordinator for Connect C at Burnet Institute, Nicole is working with Australian health authorities and community to co design interventions aimed at overcoming barriers in the utilisation of notifications systems. Prior to Burnet, Nicole delivered health programs in hepatitis C, Spinal Surgery, Pain management and medical examinations.
A/Prof Behzad Hajarizadeh
Associate Professor
The Kirby Institute, UNSW
Anti-viral treatment levels among treatment-eligible people living with chronic hepatitis B in Australia: The REACH-B Study
12:05 PM - 12:20 PMBiography
A/Prof Hajarizadeh trained as a Medical Practitioner and has a Masters in Public Health and PhD in Medicine (Clinical Epidemiology). His main area of expertise is viral hepatitis with more than 15 years experience as a clinician and then researcher in the field of liver diseases.
Dr Nick Scott
Head, Modelling & Biostatistics
Burnet Institute
Return on investment for a prison-based needle and syringe program in Australia
12:20 PM - 12:35 PMBiography
Associate Professor Nick Scott is the head of Modelling and Biostatistics at the Burnet Institute. He uses economic modelling to inform public health policy.
Ms Andrea Pizzie
Lead Policy Analyst
Hepatitis Australia
Dr. Guillaume Fontaine
Assistant Professor
UNSW / Kirby Institute
Evaluating the impact theory of the National Australian Hepatitis C Point-of-Care Testing Program: An implementation science-informed study
12:40 PM - 12:45 PMBiography
Dr. Guillaume Fontaine is an Assistant Professor at McGill University, and a Visiting Fellow at the Kirby Institute, UNSW Sydney.
As an implementation scientist, he navigates the complex terrain of bringing scientific advancements into everyday use, devising strategies to overcome barriers and ensure that research findings effectively enhance healthcare outcomes.
Chairperson
Greg Dore
Head, Viral Hepatitis Clinical Research Program, Infectious Disease Physician St Vincent’s Hospital Sydney
The Kirby Institute
Alisa Pedrana
Senior Research Fellow
Burnet Institute